Latest Updates & News
Zurzuvae approved for treatment of postpartum depression on August 04, 2023
What is Zurzuvae prescribed for? Zurzuvae is prescribed to treat postpartum depression in adults. What is the name of the drug and what does it do? Zurzuvae, pronounced ZUR-zoo-vay, (generic name: zuranolone) is a medication approved for treating postpartum depression (PPD) in adults. It belongs to a class of drugs known as neuroactive steroids, which...
Voquezna approved for Erosive Esophagitis and GERD by FDA on November, 2023
What is Voquezna prescribed for? Voquenza is indicated for the treatment of Helicobacter pylori (H. pylori) infection in adults. What is the name of the drug and what does it do? Voquezna, pronounced voh-kez-nah, (generic name:vonoprazan) recently approved by the FDA, is a medication designed to treat erosive esophagitis and gastroesophageal reflux disease...
Why Whooping Cough Cases Are Rising in the U.S
What did the research discover? Recent data from the U.S. Centers for Disease Control and Prevention (CDC) shows a significant rise in whooping cough (also known as pertussis) cases. For the week ending September 14, 2024 there were 291 new cases were reported, with New York and Oklahoma experiencing the highest numbers. So far in 2024, the U.S. has recorded over...
FluMist: A Convenient New Way to Protect Yourself from the Flu with At-Home Administration
What did the research discover? The U.S. Food and Drug Administration (FDA) has approved FluMist for self- or caregiver-administration. FluMist is a nasal spray vaccine that helps prevent the flu (influenza) in people aged 2 through 49. While FluMist has been around since 2003, it previously had to be administered by a healthcare provider. Now, it can be given by...